Monitor Progress: Keep track of your weight loss and energy levels over time to determine the injections effectiveness
External resources SURMOUNT-5 Trial: Tirzepatide vs Semaglutide for Obesity (New England Journal of Medicine) SURPASS-2 Trial: Tirzepatide vs Semaglutide for Type 2 Diabetes (New England Journal of Medicine) Tirzepatide Dual GIP/GLP-1 Receptor Agonist Mechanism (JCI Insight) Why Weight Loss Drugs Do Not Work for Everyone: Genetics (Scientific American) Factors Associated with Weight Loss Response to GLP-1 Analogues (PMC) In case I do not see you, good afternoon, good evening, and good night
Cells 12 , 500 (2023)
The general idea is that NAION occurs because cells begin to swell in the very tight space at the optic nerve head
Novartis Pluvicto shows clinically meaningful and highly statistically significant rPFS benefit in patients with PSMA-positive metastatic castration-resistant prostate cancer in the pre-taxane setting
PubMed Yang, L., Wang, Y., Dong, X., Chen, Y., Li, X., Li, L., Zheng, C., Cao, C., Zhang, H., Huang, W., Zhang, C., Yang, D., Zhao, Q., Wu, B., & Shen, D.D